Nordea Investment Management AB Makes New Investment in Sotera Health Company $SHC

Nordea Investment Management AB bought a new stake in shares of Sotera Health Company (NASDAQ:SHC) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 107,822 shares of the company’s stock, valued at approximately $1,908,000.

A number of other hedge funds have also recently modified their holdings of the business. GAMMA Investing LLC raised its holdings in shares of Sotera Health by 31.1% in the fourth quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock worth $86,000 after buying an additional 1,161 shares during the period. JPMorgan Chase & Co. boosted its holdings in Sotera Health by 1.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 237,576 shares of the company’s stock valued at $3,737,000 after acquiring an additional 3,323 shares during the period. New Mexico Educational Retirement Board grew its position in Sotera Health by 80.2% in the 3rd quarter. New Mexico Educational Retirement Board now owns 36,400 shares of the company’s stock valued at $573,000 after acquiring an additional 16,200 shares during the last quarter. Hudson Bay Capital Management LP bought a new position in Sotera Health in the 3rd quarter valued at $3,932,000. Finally, Alpine Global Management LLC purchased a new stake in Sotera Health in the third quarter worth $342,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

SHC stock opened at $13.13 on Friday. Sotera Health Company has a 1-year low of $9.53 and a 1-year high of $19.85. The business has a 50-day moving average price of $16.28 and a 200 day moving average price of $16.58. The company has a market capitalization of $3.73 billion, a P/E ratio of 48.63 and a beta of 1.84. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to analysts’ expectations of $300.68 million. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, equities research analysts forecast that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Analyst Ratings Changes

SHC has been the subject of several research analyst reports. Zacks Research downgraded Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Citigroup raised their price target on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Wells Fargo & Company cut shares of Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Finally, Piper Sandler upgraded shares of Sotera Health from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $17.00 to $24.00 in a research note on Friday, January 9th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $20.43.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the transaction, the director directly owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. This trade represents a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 47.55% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.